Evidence map›Paper›PMID 40143105›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Nanostructured Strategies for Melanoma Treatment-Part I: Design and Optimization of Curcumin-Loaded Micelles for Enhanced Anticancer Activity.

Valentina Paganini, Andrea Cesari, Silvia Tampucci, Patrizia Chetoni, Susi Burgalassi, Michele Lai, Giulia Sciandrone, Silvia Pizzimenti, Fabio Bellina, Daniela Monti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Valentina PaganiniDepartment of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.ORCID 0000-0002-5864-2845
Andrea CesariDepartment of Chemistry and Industrial Chemistry, University of Pisa, 56124 Pisa, Italy.ORCID 0000-0002-9927-0953
Silvia TampucciDepartment of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.ORCID 0000-0002-8927-6083
Patrizia ChetoniDepartment of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.ORCID 0000-0003-4790-4683
Susi BurgalassiDepartment of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.ORCID 0000-0002-0795-2886
Michele LaiRetrovirus Center and Virology Section, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56100 Pisa, Italy.ORCID 0000-0001-7597-123X
Giulia SciandroneRetrovirus Center and Virology Section, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56100 Pisa, Italy.
Silvia PizzimentiDepartment of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.ORCID 0000-0002-6230-5681
Fabio BellinaDepartment of Chemistry and Industrial Chemistry, University of Pisa, 56124 Pisa, Italy.ORCID 0000-0002-4939-7008
Daniela MontiDepartment of Pharmacy, University of Pisa, Via Bonanno 33, 56126 Pisa, Italy.ORCID 0000-0001-7622-4367

Funding

European Union's NextGenerationEU initiative under the Italian Ministry of University and Research PNRR - M4C2-I1.3 Project PE00000019 'HEAL ITALIA', CUP I53C22001440006University of Pisa PRA 2022_19
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

curcumindrug delivery systemshigh-content imaging systemmelanoma skin cancermicellesnanotechnologyresponse surface methodology (RSM)TPGS

Identifiers

PMID40143105
PMCPMC11945392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.